Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
Submitted by
CP Staff
on June 21, 2018 - 9:44am
Source:
CP Wire
News Tags:
Heron Therapeutics
HTX-011
pain management
post-operative pain
Headline:
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
snippet:
Combination of local anesthetic bupivacaine and anti-inflam meloxicam
Applied directly to site of injury
Company expects to submit NDA in second half of 2018
Do Not Allow Advertisers to Use My Personal information
